Literature DB >> 17157251

The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site.

Tudor Moldoveanu1, Qian Liu2, Ante Tocilj2, Mark Watson3, Gordon Shore4, Kalle Gehring5.   

Abstract

BAK/BAX-mediated mitochondrial outer-membrane permeabilization (MOMP) drives cell death during development and tissue homeostasis from zebrafish to humans. In most cancers, this pathway is inhibited by BCL-2 family antiapoptotic members, which bind and block the action of proapoptotic BCL proteins. We report the 1.5 A crystal structure of calpain-proteolysed BAK, cBAK, to reveal a zinc binding site that regulates its activity via homodimerization. cBAK contains an occluded BH3 peptide binding pocket that binds a BID BH3 peptide only weakly . Nonetheless, cBAK requires activation by truncated BID to induce cytochrome c release in mitochondria isolated from bak/bax double-knockout mouse embryonic fibroblasts. The BAK-mediated MOMP is inhibited by low micromolar zinc levels. This inhibition is alleviated by mutation of the zinc-coordination site in BAK. Our results link directly the antiapoptotic effects of zinc to BAK.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157251     DOI: 10.1016/j.molcel.2006.10.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  102 in total

1.  Bax dimerizes via a symmetric BH3:groove interface during apoptosis.

Authors:  G Dewson; S Ma; P Frederick; C Hockings; I Tan; T Kratina; R M Kluck
Journal:  Cell Death Differ       Date:  2011-10-21       Impact factor: 15.828

2.  Bax forms an oligomer via separate, yet interdependent, surfaces.

Authors:  Zhi Zhang; Weijia Zhu; Suzanne M Lapolla; Yiwei Miao; Yuanlong Shao; Mina Falcone; Doug Boreham; Nicole McFarlane; Jingzhen Ding; Arthur E Johnson; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

3.  BH3 domains other than Bim and Bid can directly activate Bax/Bak.

Authors:  Han Du; Jacob Wolf; Blanca Schafer; Tudor Moldoveanu; Jerry E Chipuk; Tomomi Kuwana
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

4.  Heterodimerization of BAK and MCL-1 activated by detergent micelles.

Authors:  Qian Liu; Kalle Gehring
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

5.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX.

Authors:  Bonsu Ku; Chengyu Liang; Jae U Jung; Byung-Ha Oh
Journal:  Cell Res       Date:  2010-11-09       Impact factor: 25.617

6.  Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers.

Authors:  Kyoung Joon Oh; Pawan Singh; Kyungro Lee; Kelly Foss; Shinyoub Lee; Minji Park; Steffi Lee; Sreevidya Aluvila; Matthew Park; Puja Singh; Ryung-Suk Kim; Jindrich Symersky; D Eric Walters
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

7.  Mutation to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis.

Authors:  Peter E Czabotar; Erinna F Lee; Geoff V Thompson; Ahmad Z Wardak; W Douglas Fairlie; Peter M Colman
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

8.  BH3-triggered structural reorganization drives the activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Marguerite L Davis; Gregory H Bird; Loren D Walensky
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

Review 9.  The Bcl-2 apoptotic switch in cancer development and therapy.

Authors:  J M Adams; S Cory
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

10.  A three-helix homo-oligomerization domain containing BH3 and BH1 is responsible for the apoptotic activity of Bax.

Authors:  Nicholas M George; Jacquelynn J D Evans; Xu Luo
Journal:  Genes Dev       Date:  2007-08-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.